The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
about
Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266WGenome-wide association analysis of autoantibody positivity in type 1 diabetes cases.Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis.Gestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1*0602 genotypes and islet cell autoantibodies.Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.Type I interferon in organ-targeted autoimmune and inflammatory diseases.Beta-cell specific autoantibodies: Are they just an indicator of type 1 diabetes?Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.C1858T Polymorphism of Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN22): an eligible target for prevention of type 1 diabetes?A novel single nucleotide polymorphism in the protein tyrosine phosphatase N22 gene (PTPN22) is associated with Type 1 diabetes in a Chinese population.Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.PTPN22 gene polymorphism (C1858T) is associated with susceptibility to type 1 diabetes: a meta-analysis of 19,495 cases and 25,341 controls.
P2860
Q28482717-7E8AE0DD-4EFA-42A5-88F6-F131474364D5Q29417005-F1ACD13E-0D5D-415B-A752-DFBFDCB9CB5DQ30301275-0D6F8D70-0A45-4068-8F04-23D26B682E1AQ33403872-BC8E1DC7-62B8-4296-941B-9B4097A7E4F6Q34229909-1CE08F5D-E955-4511-A872-FE64E16950FDQ35205805-58D687F8-D09A-40F9-9987-0ADED1C3432AQ36348307-34C4F2F6-8F33-425A-A64B-FAD82B35C55EQ37838003-BB124E13-D737-4495-9640-42FF9F2A7BB8Q38818303-343F4FBB-4579-45F6-A857-09A96B9FC4BCQ38904874-2B27FD3D-A87D-4603-AA45-F7AC44C6F4D1Q39022002-E84E7804-C150-41FD-8D1B-911F2E0EA5BFQ43843220-D9D72DFF-E020-4BF4-975C-BEA214E3F7E5Q45342213-79352F92-2757-4C22-97CA-ADB4181D76C3Q50950195-BBC28108-12E4-4333-B930-544AB1A89BA3Q51271075-04CD04F7-E5B0-4FF6-9D46-20A7E653B5B7
P2860
The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The association between the PT ...... risk and GAD65 autoantibodies.
@ast
The association between the PT ...... risk and GAD65 autoantibodies.
@en
The association between the PT ...... risk and GAD65 autoantibodies.
@nl
type
label
The association between the PT ...... risk and GAD65 autoantibodies.
@ast
The association between the PT ...... risk and GAD65 autoantibodies.
@en
The association between the PT ...... risk and GAD65 autoantibodies.
@nl
prefLabel
The association between the PT ...... risk and GAD65 autoantibodies.
@ast
The association between the PT ...... risk and GAD65 autoantibodies.
@en
The association between the PT ...... risk and GAD65 autoantibodies.
@nl
P2093
P2860
P356
P1433
P1476
The association between the PT ...... risk and GAD65 autoantibodies.
@en
P2093
A Lernmark
C B Sanjeevi
Diabetes Incidence in Sweden Study Group
J P Palmer
Swedish Childhood Diabetes Register
W Hagopian
P2860
P2888
P304
P356
10.1038/GENE.2010.12
P577
2010-05-06T00:00:00Z
P5875
P6179
1038504318